Search Results

Showing results 1971 - 1980 for weill cornell connect patient portal

Small Molecules that Protect Against Lipofuscin Toxicity to Prevent Blindness | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/small-molecules-protect-against-lipofuscin-toxicity

Iron Chelators for the Treatment of Adult Neuronal Ceroid Lipofuscinosis | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/iron-chelators-treatment-adult-neuronal-ceroid

Tumor-Derived Exomeres as Biomarkers for Cancer Detection and Monitoring | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/tumor-derived-exomeres-biomarkers-cancer-detection

Inhibitors of Fusion between Viral and Cell Membranes as well as Compositions and Methods of Using Them | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/inhibitors-fusion-between-viral-and-cell-membranes

Human Embryonic Stem Cell Research Oversight (ESCRO) | Human Research Protections

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://hrp.weill.cornell.edu/regulatory-compliance/human-embryonic-stem-cell-research-oversight-escro

Immunoglobulin D Enhances Antimicrobial Immunity by Activating Basophils | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/immunoglobulin-d-enhances-antimicrobial-immunity

Correction of a murine model of von Willebrand disease by gene

...Connect Departments Alumni News Events Weill Cornell Medicine....

https://geneticmedicine.weill.cornell.edu/publications/correction-murine-model-von-willebrand-disease-gene-transfer

3-phosphoglycerate Dehydrogenase (PHGDH) Inhibitors | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/3-phosphoglycerate-dehydrogenase-phgdh-inhibitors

VEGF for the Treatment of Peripheral Nerve Damage | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/vegf-treatment-peripheral-nerve-damage

Automated Intracytoplasmic Sperm Injection Device | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/automated-intracytoplasmic-sperm-injection-device

Showing results 1971 - 1980 for weill cornell connect patient portal